A number of studies, such as tissue expression experiments, animal models, and clinical trials suggest that RAD51 plays an important role in carcinogenesis, and numerous research groups have analyzed the link between RAD51 polymorphisms and cancer risk (Cheng et al. 2014; Maacke et al. 2000; Vispe et al. 1998). The gene discussed is RAD51; the disease is cancer.